NunaBio secures £6.5 million to scale DNA manufacturing platform
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Subscribe To Our Newsletter & Stay Updated